Abound Wealth Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Abound Wealth Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$81	Hold	4	–	–	﹤0.01%	1316
2026 Q1	$79	Hold	4	–	–	﹤0.01%	1449
2025 Q4	$108	Hold	4	–	–	﹤0.01%	1373
2025 Q3	$107	Hold	4	–	–	﹤0.01%	1299
2025 Q2	$92	Hold	4	–	–	﹤0.01%	1266
2025 Q1	$116	Hold	4	–	–	﹤0.01%	1199
2024 Q4	$149	Hold	4	–	–	﹤0.01%	1170
2024 Q3	$195	Sell	4 -2	-33%	-$88	﹤0.01%	1179
2024 Q2	$240	Hold	6	–	–	﹤0.01%	1055
2024 Q1	$264	Buy	+6	New	+$310	﹤0.01%	1181
2023 Q4	–	Sell	-6	Closed	-$276	–	1348
2023 Q3	$276	Hold	6	–	–	﹤0.01%	1038
2023 Q2	$345	Buy	+6	New	+$266	﹤0.01%	991

Other funds holding AMPH

LAM Group Lake Oswego, Oregon $201M AUM 22.35% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SWP

Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

1IA

1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Abound Wealth Management's AMPH Position: Q2 2026 in Review

Abound Wealth Management held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 4 shares worth $81. The position accounts for ﹤0.01% of the portfolio, ranked #1316.

Abound Wealth Management first reported a position in AMPH in Q2 2023 and has held it in 12 quarters since. The position peaked at $345 in Q2 2023. 20 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

Abound Wealth Management held 4 shares of Amphastar Pharmaceuticals worth $81 as of Q2 2026.
Abound Wealth Management left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
Amphastar Pharmaceuticals made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #1316 holding.
Abound Wealth Management first reported a position in Amphastar Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
Abound Wealth Management's Amphastar Pharmaceuticals position peaked at $345 in Q2 2023.
20 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.